[1]
K. O. Zupanets, V. Y. Dobrova, and T. Y. Kolodyezna, “Study of the trial subjects’ protection aspects in Phase I clinical trials and bioequivalence studies”, Zaporozhye Medical Journal, vol. 18, no. 2, May 2016.